Q/C Technologies, Inc. Asset Acquisition Consideration Transferred Contingent Consideration
Q/C Technologies, Inc. (QCLS) reported Asset Acquisition Consideration Transferred Contingent Consideration of $9.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Asset Acquisition, Consideration Transferred
us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration · last filed 2026-08-12
- Q/C Technologies, Inc. asset acquisition consideration transferred contingent consideration for the quarter ending 2026-06-30 was $0.00.
- Q/C Technologies, Inc. asset acquisition consideration transferred contingent consideration for the quarter ending 2026-03-31 was $9.38M.
- Q/C Technologies, Inc. asset acquisition consideration transferred contingent consideration for fiscal 2025 was $9.38M.
| Period end | Asset Acquisition Consideration Transferred Contingent Consideration | Asset Acquisition Consideration Transferred Contingent Consideration 3 month | Asset Acquisition Consideration Transferred Contingent Consideration 6 month | Asset Acquisition Consideration Transferred Contingent Consideration 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $9.38M 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $9.38M 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $9.38M 10-K · filed 2026-04-15 | |||
| 2025-09-02 | $9.38M 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |